Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Insulin dimer-incretin conjugates

Insulin dimer-incretin conjugates

US Patent 11058775 · Granted Jul 13, 2021

Estimated economic value: $96,899,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-responsive insulin conjugates2025
Glucose-responsive insulin conjugates2025
Small molecule inhibitors of KRAS G12C mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
Arginase inhibitors and methods of use2025
Arginase inhibitors and methods of use2025
Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc2023
Conjugate based systems for controlled insulin delivery2023
Conjugate based systems for controlled insulin delivery2023
Conjugate based systems for controlled insulin delivery2023
Small molecule inhibitors of KRAS G12C mutant2023
Long-acting co-agonists of the glucagon and GLP-1 receptors2023